María Jesús Salido Rojo

🌍 The Global Digital Compact: A Milestone for #Health 🏥 Yesterday’s adoption of the Global Digital Compact at #UNGA represents a major step forward in shaping the future of digital cooperation and innovation across the globe. At D-tree, we believe that closing the digital divide and advancing responsible data use and governance are crucial to improving healthcare for all. Through our work across Sub-Saharan Africa, we've seen firsthand how digital innovations can transform healthcare systems, empower health workers and provide people with the right care, at the right place and at the right time. Read our reflections about the Compact ➡ https://lnkd.in/d6fZ9tXX

20

Come join us at #SCOPEsummit Europe in Barcelona for an insightful panel discussion on integrating Digital Health Technologies in Clinical Trials: A New Era for eCOA and ePRO with Jacqueline Bowman, LLB, MBA, Kai Langel, and Bernhard Glombitza. We will explore how emerging digital health technologies, particularly eCOA and ePRO, are reshaping patient data collection in clinical trials. Discover the evolution of digital endpoints, patient-centric strategies, and the incorporation of these technologies into clinical research frameworks. How are eCOA and ePRO solutions revolutionizing data collection in clinical trials? Have they enhanced the patient-centricity of trials? Explore the challenges in integrating these technologies into existing clinical trial structures and the strategies for overcoming them. What factors should be considered when selecting technology partners? Looking ahead, let's discuss the future of digital health technologies and their impact on clinical research. Join the conversation to gain valuable insights into the evolving landscape of digital health technologies in clinical trials at #SCOPEsummit. Micah Lieberman Rich Handy Melissa M. Dolen Erin Kadelski

18

Raindrops are a great metaphor for the #digitaltransformation of Healthcare. What do I mean? The promises of the digital health revolution are many. Decreased workload, improved diagnostics, improved efficiency, greater access, enabling technologies etc. Furthermore, their wide adoption seems imminent! Not only does it make sense, but in every other industry, those same technologies are in place and delivering on their promise. In fact, the digial revolution should hit healthcare like a tsunami and allow us to start over on some version of the medical bay on the Starship Enterprise. It is a cruel experiment: your car drives you to work but when you get there, you are faxing patient referrals. A patient can book an international flight but when they try to book a clinic appointment, the task is insanely complicated. But not everywhere. At Kaiser Permanenet in NCAL, it is faster to book an online appointment than to do it on the phone (I did it). Some patients have the benefit of a sci-fi avatar driven all knowing virtual assistant to help them recover from surgery. A couple of posts back, I talked about the speed at which smaller hospital groups are able to adopt new technology efficiently. Unburdened by legacy tech stacks and outdated leadership models, they can actually identify pain points for which there are mature digital solutions and implement them. Done. Each of these smaller groups, or digitally enabled private practices, represents a rain drop of technological adoption. Over time, adjacent raindrops will coalesce, competition will lead to curiosity, curiosity will lead to familiarity, familiarity to trust, and trust to broad adoption. In the 1990s, many proclaimed that sequencing the human genome would usher in a wave of cancer cures within a decade. Nearly 40 years later, we are starting to see some raindrops. Today, it's AI. We hoped that a computer science tsunami would wipe the healthcare slate clean, but instead, we are getting raindrops of success and people are either surprised or disappointed. We should not be. For each raindrop, in that location, the job is done. Eventually, others join in. The network effect grows. And it grows quickly. So: go ahead, be a raindrop. Lead the pack. Forge the way where it makes sense. You won’t be alone for long. What do you think? Is this a good visual to explain how innovation spreads in healthcare and why it pays to be an innovator? Mohan Nair Logan Plaster Daniel Kraft, MD John Nosta Professor Shafi Ahmed Fabrizio Billi Gil Bashe Mark Froimson MD, MBA Ivan Tornos Todd S. Eury Douglas Fairbanks Peter Birch Ali Hashemi Saul Marquez Michael Havig, MD Rafael J. Grossmann, MD, MSHS, FACS Claudio Díaz Ledezma Daniel Couchman Kendall MPH Sanjeev Agrawal

34

9 comentarios

[Webinar] Join us for an exclusive webinar on Digital Health Intelligence’s new Bevan.ai AI chatbot.   📅 When? Wednesday, 11 December 2025 🕐 Time? 12:30 – 13:30 Learn more Bevan.ai beta, Digital Health Intelligence’s new dedicated LLM AI model trained by healthcare leaders to help users better understand current and planned use of digital and data across the English NHS.   Here’s what Bevan brings to the table: ➡️ Access insights from over 3,000 NHS trust and ICB Board papers, annual plans, and strategy documents. ➡️ Save time and uncover value locked away in PDFs with ease. ➡️ Ask anything—from broad digital adoption trends to specific NHS trust priorities and needs.   Bevan.ai is available exclusively to Intelligence subscribers on Professional, Advanced, and Premium packages for free for a limited time. Non-subscribers are invited to attend this webinar to find out more.   Presenters: ➡️ Jon Hoeksma - CEO, Digital Health ➡️ Emmanuel Phillips - Research Manager, Digital Health Intelligence ➡️ Karl Grundy - Deputy MD, Digital Health   #AI #DigitalHealth #BevanAI #HealthcareInnovation #NHS   Register now > https://lnkd.in/dtEK6Mqu

4

Spain’s Ministry of Health has released the new Health Technology Assessment (HTA) Royal Decree for public consultation, introducing updated guidelines for evaluating drugs, medical devices, and other health technologies. Here are three key points: 1. Two-Tier Evaluation System: The decree establishes a clear distinction between clinical and non-clinical evaluations, including economic factors. 2. Increased Transparency: Developers must now provide detailed cost data, ensuring that evaluations remain independent of funding decisions. 3. Stakeholder Involvement: The new framework mandates input from patients and healthcare professionals before technologies are integrated into the National Health System (SNS). As these changes reshape the landscape, it's crucial for pharmaceutical and medical technology companies to adapt swiftly. Lyfegen can help you stay ahead with our cutting-edge solutions: - Navigate New Regulatory Requirements: Access our extensive Agreements Library, featuring over 5,000+ public drug pricing agreements and 20 pricing models, to ensure compliance with the latest HTA standards. - Optimize Decision-Making: Utilize our Drug Contracting Simulator to create data-driven business cases and run real-time simulations that align with Spain's new HTA guidelines. - Streamline and Automate Contracting: Our Rebate Analytics solutions automate rebate and refund calculations, ensuring accuracy, transparency, and a significant reduction in administrative burdens. Book a demo with us today to explore how Lyfegen’s tools and expertise can support your business under Spain’s new HTA framework. Book your demo here: https://hubs.la/Q02L3LFB0 #HTASpain #SpainHealth #HealthTechnology #PharmaSpain #MedTechSpain #HealthcareRegulations #ValueBasedCare #HealthcareInnovation

15

IDERHA partner The European Institute for Innovation Through Health Data (i~HD) just announced its Annual Conference will take place on 27 and 28 November in Bilbao. The focus of the meeting will be equitable, integrative, and value-driven digital health transformation. "𝐷𝑖𝑔𝑖𝑡𝑎𝑙 𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑖𝑠 𝑛𝑜𝑡 𝑠𝑖𝑚𝑝𝑙𝑦 𝑎𝑏𝑜𝑢𝑡 𝑝𝑢𝑟𝑐ℎ𝑎𝑠𝑖𝑛𝑔 𝑛𝑒𝑤 𝑡𝑒𝑐ℎ𝑛𝑜𝑙𝑜𝑔𝑦, 𝑏𝑢𝑡 𝑎 𝑠𝑦𝑠𝑡𝑒𝑚𝑖𝑐 𝑐ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑤𝑎𝑦 ℎ𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒 𝑜𝑟𝑔𝑎𝑛𝑖𝑠𝑎𝑡𝑖𝑜𝑛𝑠 𝑎𝑛𝑑 𝑝𝑟𝑜𝑓𝑒𝑠𝑠𝑖𝑜𝑛𝑎𝑙𝑠 𝑑𝑒𝑙𝑖𝑣𝑒𝑟 𝑐𝑎𝑟𝑒 𝑎𝑛𝑑 𝑐𝑜𝑜𝑝𝑒𝑟𝑎𝑡𝑒 𝑤𝑖𝑡ℎ 𝑒𝑎𝑐ℎ 𝑜𝑡ℎ𝑒𝑟 𝑎𝑛𝑑 𝑤𝑖𝑡ℎ 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠", says Dipak Kalra, president of i~HD. Key themes for keynotes and panel discussions: 🔵 Sustainability and resilience to ensure stronger health systems and enhance patient outcomes 🔵 Patient empowerment and equity through digital health 🔵 Technical requirements and demonstrations of innovative digital solutions 🔵 Scale up strategies and challenges 🔵 Accelerated digital adoption, including innovative reimbursement models. IDERHA industry lead Christian Muehlendyck stresses the importance of these topics: "𝑇ℎ𝑒 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛𝑠 𝑖𝑛 𝐼𝐷𝐸𝑅𝐻𝐴 𝑎𝑟𝑒 𝑘𝑒𝑦 𝑓𝑜𝑟 𝑝𝑒𝑟𝑠𝑜𝑛𝑎𝑙𝑖𝑧𝑒𝑑 ℎ𝑒𝑎𝑙𝑡ℎ 𝑐𝑎𝑟𝑒. 𝑁𝑜𝑡 𝑜𝑛 𝑡ℎ𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑙𝑒𝑣𝑒𝑙, 𝑎𝑠 𝑖𝑛 𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑒𝑢𝑡𝑖𝑐𝑎𝑙 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛𝑠, 𝑏𝑢𝑡 𝑏𝑎𝑠𝑒𝑑 𝑜𝑛 𝑝𝑒𝑟𝑠𝑜𝑛𝑎𝑙 ℎ𝑒𝑎𝑙𝑡ℎ 𝑑𝑎𝑡𝑎." This conference is your chance to connect, learn, and contribute. Be ready to put your questions to the panels of your choice and to enjoy the wonderful city of Bilbao! ➡ Discover the programme and register here: https://www.i-hd.eu/ac2024 #patientengagement #datascience #AI #machinelearning #realworlddata #RWD #realworldevidence #RWE #datainfrastructure #dataaccess #remotemonitoring #healthdata #healthdataspace #healthpolicymaking #HTA #EHDS #lungcancer

29

1 comentario

The opportunities of #healthcareAI in early #LungCancer detection discussed in Madrid, Spain with global luminaries at the 𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲 𝗳𝗼𝗿 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗟𝘂𝗻𝗴 𝗮𝗻𝗱 𝗖𝗮𝗿𝗱𝗶𝗮𝗰 𝗘𝗮𝗿𝗹𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 aka AGILE.     Thank you International Early Lung Cancer Action Program (I-ELCAP) and iDNA - The Institute for DiagNostic Accuracy for organizing a thought-provoking forum. The conference enabled collaboration, engagement and knowledge development on meeting the challenges of early disease identification.     Each year, lung cancer claims more lives than breast, colon, prostate and ovarian cancer combined. Questing for #earlydetection means that treatment options are more effective and survival rates increase.     #healthtech #medicaldevices #medicalimaging #artificialintelligence #oncology #earlylungcancerdetection Bhargava Reddy Sagar Sen Preetham Putha Ranjana Devi Georgina Wright Ketaki Kakade Nikunj Mohota Aman Garg Samir Shah, MD, MMM FACR Surabhi Srivastava Rakhee Krishnan

88

2 comentarios

👉🏼 RELATIONAL DIMENSION VERSUS ARTIFICIAL INTELLIGENCE 🤓 Juan Rodado 👇🏻 https://lnkd.in/es8FmX_Q 🔍 Focus on data insights: - Utilization of deep learning models in healthcare - Evolution and prominence of artificial intelligence tools - Impact on medical diagnosis and patient care 💡 Main outcomes and implications: - Transformation in subjective expression in healthcare - Importance of relational dimension in psychotherapeutic treatment - Validity of psychoanalytic approach in contrast to AI treatment models 📚 Field significance: - Healthcare transformation through AI tools - Integration of AI in medical and psychological fields - Implications for patient care and treatment 🗄️: [#artificialintelligence #healthcare #datainsights #psychotherapy]

1

As this excellent article describes so well, the #AI field (and not just in the #health, #healthcare, and #digitalhealth #innovation & #technology areas on which I tend to focus most ) is moving beyond narrow, specialized models and towards the development of highly capable, autonomous and automated workers or “agents” that can truly augment and enhance human intelligence across a wide range of domains. This shift towards AI agents promises to profoundly change the way we work, live, and interact with technology, ushering in a new era of intelligent, adaptive, and increasingly useful AI systems. An AI agent’s architecture encompasses the essential components that empower it to think, plan, and act within its environment. The main question for organizations everywhere then is which agents to choose (the fitness-for purpose’ question, How safe and secure is it, what #data set do I point it at (private and public)? and finally what is the best ‘work’ project or challenge to best point it at to save time and money, and/or increase efficiency, effectiveness, quality. As usual, thoughts appreciated. #Entrepreneurship #dataanalytics #work #interoperability #jtbd #growthmindset #openai #criticalthinking #LLM #machinelearning #nlp #chatbots #FutureOfWork https://lnkd.in/gxp6YQYk

12

6 comentarios

🚀 Join Us for the Second Webinar of the Remote Areas Thematic Innovation Ecosystem! We're excited to invite you to our upcoming webinar on September 17th, 2024, from 10:00 to 11:00 CET, co-led by ECHAlliance and the DigitalHealthUptake project. This session will focus on the Uptake of Digital Health Solutions in Remote Areas. 🌍 This webinar will delve into: - Implementation Phase: Explore the opportunities, challenges, and adoption of digital health solutions among older populations in remote areas. - Sustainability: Discuss the financial and strategic aspects needed to ensure these solutions can be scaled widely. Don't miss this opportunity to learn and share insights on how we can drive sustainable health innovations in remote regions. 📅 Date: September 17, 2024 from 10:00 to 11:00 CET 📍 Location: Online 👉 Register Now to secure your spot and be part of this important conversation! https://lnkd.in/d5EhabwX Project Consortium: empirica Communication and Technology Research | DIGITALEUROPE | The European Institute for Innovation Through Health Data | EHTEL - Collaborating for Digital Health and Care in Europe | ECHAlliance - The Global Health Connector | RSCN (AHA - Reference Site Collaborative Network) | F6S Innovation #DigitalHealth #Innovation #RemoteAreas #Healthcare #Sustainability #HealthyAgeing

8

📢 The Barcelona Health Hub ecosystem is making headlines again! BHH member IOMED was featured at EL ESPAÑOL Invertia for revolutionizing clinical data exchange in Europe using #AI. IOMED's AI-driven platform is enabling hospitals to communicate seamlessly, not only enhancing research but also ensuring better patient care. Gabriel Maeztu, Co-Founder at IOMED, shares their ambition to become the largest European player for structured and interoperable clinical data by 2026. As digital health continues to expand, 'the success of IOMED underscores the strength of Barcelona’s healthtech ecosystem, which is becoming a global leader in #healthcare innovation,' states BHH's Luis Badrinas. Read the whole article here: https://lnkd.in/dKdJWzQf

18

🌟 Learn more about the DIHsP4_Medicine project and its mission to activate the P4 Paradigm in Medicine! We're building a 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧 𝐏𝐥𝐚𝐧 to encourage collaboration among Digital Innovation Hubs across Europe, driving the development and adoption of Personalized, Predictive, Preventive and Participatory (P4) Medicine. The JAP comprises three main strategic lines, based on the EU health priorities and on a common set of priorities, challenges and needs of health sector stakeholders identified during the initial research and dialogue phase of the DIHsP4_Medicine project. Find out more about the 𝐟𝐢𝐫𝐬𝐭 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐋𝐢𝐧𝐞 here ⬇⬇⬇

4

📹 Join our webinar on the impact of Decentralized Data Collection on Clinical Practice: Use Cases of Primary & Secondary Use of RWD After last year’s insightful webinar on patient engagement, we’re back with a follow-up focused on data and its role in transforming healthcare. Last year we hosted a webinar on patient engagement programs. One key takeaway was the need for a follow-up event with a special focus on “data”. This event is designed for pharma companies, MedTech companies, physicians, and hospital C-level executives who are looking to learn more about real-world data (RWD) and its practical uses in both patient care and clinical research. 💡 What You’ll Learn: - How care providers are leveraging data insights in daily practice - How data motivates patients and enhances engagement - Interaction with EMR using the FHIR standard - Practical use cases of data for clinical market access, research, and registries 🔎 Program Highlights: 1. Decentralized Real-World Data Collection: Discover the benefits and challenges of collecting RWD. 2. Primary Use Cases: Real-world examples of how RWD improves patient care and clinical decision-making. 3. Secondary Use Cases: Exploring RWD’s role in research, regulatory applications, and pharma.  📅  Date & Time: October 9th, 12:30 - 1:30 pm (CEST) 📍  Location: Online – join from anywhere!   📝 Register Now to unlock the power of real-world data and its impact on healthcare innovation We're excited to announce our first confirmed speakers : Magnus Enerbäck, Archange NIGAR, Matthias Lannoo, Jing Xie, Bob Moens, Ward Servaes, Charles-Eric Winandy, Andries Pauwels... stay tuned for more updates! Thanks to IQVIA Belux Kaatje Verloes Manu Patteet Patrick Van Dooren Bob Moens Louise Pannier for the organization!

19

1 comentario

👩🏻‍⚕️ It's no news #healthcare is undergoing a deep transformation. One key development is the concept of Value Based Care (VBC), which shifts responsability from patients to health proiders (you can gain a deeper understadning in our research about it ➡ https://lnkd.in/dZDZFpPp). 🦾 But now, with #AI as a key player, the possibilities of VBC have expanded, specially regarding #CareCoordination. Our latest blog explores: ✅ Why Value-Based Care is the new frontier ✅ How AI is supercharging patient-centric care ✅ Game-changing AI solutions in action ✅ The AI-VBC impact on #CareCoordination Whether you're in health tech or looking to innovate your healthcare practice, this is a must-read! 👉 Explore the future of healthcare and its potential here: https://lnkd.in/d2WAxW2K

3

AI and HTA medical devices "The adaptation of the HTA process through a methodological framework for AI-based medical devices enhances the comparability of results across different evaluations and jurisdictions. By defining the necessary expertise, the framework supports the development of a skilled workforce capable of conducting robust and reliable HTAs of AI-based medical devices. A comprehensive adapted HTA framework for AI-based medical devices can provide valuable insights into the effectiveness, cost-effectiveness, and societal impact of AI-based medical devices, guiding their responsible implementation and maximizing their benefits for patients and health care systems." https://lnkd.in/d659ynYF

2

1 comentario